Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Kristen Carter et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255